Monthly Archives: February 2013

Gugulipid, an Extract of Ayurveda Medicine Plant Commiphora Mukul as a Potent Agent for Cancer Chemoprevention and Cancer Chemotherapy

E-Guggulsterone Z-Guggulsterone http://www.omicsonline.org/2161-0444/2161-0444-2-e105.php?%20aid=9899 Citation: Xiao M, Xiao D (2012) Gugulipid, an Extract of Ayurveda Medicine Plant Commiphora Mukul as a Potent Agent for Cancer Chemoprevention and Cancer Chemotherapy. Med chem 2:e105. doi:10.4172/2161-0444.1000e105 Department of Urology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, … Continue reading

Posted in DRUGS, herbals | Tagged , , | Comments Off on Gugulipid, an Extract of Ayurveda Medicine Plant Commiphora Mukul as a Potent Agent for Cancer Chemoprevention and Cancer Chemotherapy

The Bingel reaction in fullerene chemistry

Bingel fullerene The Bingel reaction in fullerene chemistry The Bingel reaction in fullerene chemistry is a fullerene cyclopropanation reaction to a methanofullerene first discovered by C. Bingel in 1993 with the bromo derivative of diethyl malonate in the presence of a base such as sodium hydride or DBU.[1] The preferred double bonds for this reaction on the fullerene surface … Continue reading

Posted in ORGANIC CHEMISTRY, SYNTHESIS | Tagged , , | Comments Off on The Bingel reaction in fullerene chemistry

Organic India launches single ingredient Moringa products in US

Moringa oleifera The Drumstick Plant http://miracletrees.org/ 08 February 2013, Organic India, a manufacturer of herb-based functional supplements, has launched organic single ingredient Moringa products in the US. Available in both capsule and powder formulations, the product made from powdered leaves of … Continue reading

Posted in herbals, Uncategorized | Tagged | 2 Comments

Efficient Synthesis of Thiolactoside Glycoclusters by Ruthenium-Catalyzed Cycloaddition Reaction of Disubstituted Alkynes on Carbohydrate Scaffolds (pages 972–983)

  Efficient Synthesis of Thiolactoside Glycoclusters by Ruthenium-Catalyzed Cycloaddition Reaction of Disubstituted Alkynes on Carbohydrate Scaffolds (pages 972–983)Alejandro J. Cagnoni, Oscar Varela, María Laura Uhrig and José Kovensky European Journal of Organic Chemistry Volume 2013, Issue 5, pages 972–983, February … Continue reading

Posted in big molecules, SYNTHESIS, Uncategorized | Tagged , , , , , , | Comments Off on Efficient Synthesis of Thiolactoside Glycoclusters by Ruthenium-Catalyzed Cycloaddition Reaction of Disubstituted Alkynes on Carbohydrate Scaffolds (pages 972–983)

Immunosuppressant Drug Rapamycin Helps Preserving Female Fertility

Sirolimus (INN/USAN), also known as rapamycin, is an immunosuppressant drug used to prevent rejection in organ transplantation; it is especially useful in kidneytransplants. It prevents activation of T cells and B cells by inhibiting their response tointerleukin-2 (IL-2). A macrolide, sirolimus was discovered by Brazilian researchers as a product of the bacterium Streptomyces hygroscopicus in a … Continue reading

Posted in DRUGS, Uncategorized | Tagged , , | 1 Comment

FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders

FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders Ravicti is marketed by Hyperion Therapeutics, based in South San Francisco, Calif. February 1, 2013 — The U.S. Food and Drug Administration today approved Ravicti (glycerol phenylbutyrate) … Continue reading

Posted in NEW DRUG 2013 | Tagged | Comments Off on FDA Approves Ravicti (glycerol phenylbutyrate)for the Chronic Management of Some Urea Cycle Disorders

Chinese Plant Compound , Triptolide Wipes out Cancer in 40 Days, Say new Research.

Triptolide is a diterpenoid epoxide found in the Thunder God Vine, Tripterygium wilfordii. It has in vitro and in vivo activities against mouse models of polycystic kidney disease[1] and pancreatic cancer, but its physical properties limit its therapeutic potential.[2] Consequently, … Continue reading

Posted in Uncategorized | 3 Comments